CN106265703A - Ginsenoside Rg1's application in preparation improves body movement ability health product - Google Patents

Ginsenoside Rg1's application in preparation improves body movement ability health product Download PDF

Info

Publication number
CN106265703A
CN106265703A CN201510233880.1A CN201510233880A CN106265703A CN 106265703 A CN106265703 A CN 106265703A CN 201510233880 A CN201510233880 A CN 201510233880A CN 106265703 A CN106265703 A CN 106265703A
Authority
CN
China
Prior art keywords
ginsenoside
cell
glut4
body movement
glucose
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN201510233880.1A
Other languages
Chinese (zh)
Inventor
霍洪亮
贾胜男
李凤玉
彭雪微
王平
于清淼
孙丽丽
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Northeastern University China
Northeast Normal University
Original Assignee
Northeast Normal University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Northeast Normal University filed Critical Northeast Normal University
Priority to CN201510233880.1A priority Critical patent/CN106265703A/en
Publication of CN106265703A publication Critical patent/CN106265703A/en
Pending legal-status Critical Current

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

The invention belongs to technical field of bioengineering, be specifically related to ginsenoside Rg1's application in preparation improves body movement ability health product.

Description

Ginsenoside Rg1's application in preparation improves body movement ability health product
Technical field
The invention belongs to technical field of bioengineering, be specifically related to ginsenoside Rg1's application in preparation improves body movement ability health product.
Background technology
Raising combatant, rescue and relief work personnel, high intensity sports personnel and the motor capacity participating in various athletic competition animal are mankind's dreams for a long time.In the past, people mainly improved motor capacity by extra-nutrition material and reinforcement physical training.Showing according to the investigation of United States Olympic Committee in 2004, the athlete that there are about more than 90% supplements all kinds of nutrient substance by diet.This phenomenon the most generally exists in other high intensity muscle power staff.Nutrient substance mends sugar, salt from previously, to supplementing aminoacid, creatine and taurine in recent years, even with steroid hormone and analeptic.It is true that some nutrient substance of excessive use may bring a lot of potential risks and harm.Supplementing hormone and analeptic are played foul and relevant law especially.Along with progress and the development of science and technology, people have gradually recognized the contractile mechanism of muscle and the reason that muscle generation is tired, have recognized the mutual relation of muscle fatigue and physical fatigue.Skeletal muscle efficiency operation and the effective ways of resisting fatigue are promoted it has also been found that many.Skeletal muscle efficiency operation relates to energy matter picked-up and metabolism, myogen kind and quantity, calcium ion Rhizoma Nelumbinis connection and the many factors such as concentration, wherein, improve energy supply and picked-up be the most directly, the most controlled and most efficient method.
Glucose transporter 4 (Glucose transporter type 4 on skeletal muscle cell membrane, GLUT4) being that glucose molecule enters intracellular unique passage from skeletal muscle cell membrane, namely there is the main transporter that easyization spreads in glucose on cell membrane.It plays the effect of Skeletal Muscle Cell energy feedstuff supply pump.Its gene expression dose and film indexing decide the ingestion efficiency of glucose.GLUT4 is by 509 Amino acid profiles, and relative molecular mass is 45 000-55 000, is primarily present in skeletal muscle, cardiac muscle and fatty tissue.Under rest state, the GLUT4 overwhelming majority is distributed on intracellular vesicle film, and when insulin secretion or Motor stimulation, GLUT4 is indexed into cell membrane and structural change occurs, and carries out glucose uptake, provides energy matter for skeletal muscle activity.In body, the glucose of 85% is to directly feed skeletal muscle picked-up and utilize.Therefore, promote gene expression and the film indexing of GLUT4 in Skeletal Muscle Cell, be to increase skeletal muscle glucose supply, improve motor capacity important method and approach.
Radix Ginseng is described as " king of BAICAO " in China, is one of Relict Plant the most ancient on the earth.The most on the books at multi-section Chinese materia medica monographs such as Shennong's Herbals.Containing multiple ginsenoside and polysaccharide bioactive compound in Radix Ginseng.There is anticancer, blood sugar lowering, radioprotective, growth promotion, increasing vigor and anti-ageing function of waiting for a long time.
Ginsenoside Rg1 is one of most active bioactive ingredients in Radix Ginseng, and its pharmacological action is had made extensive and intensive studies by we.Result of study shows: ginsenoside Rg1 can promote gene expression and the film indexing of GLUT4 in Skeletal Muscle Cell, it is possible to strengthens the supply of Skeletal Muscle Cell energy, improves body movement ability.
Summary of the invention
It is an object of the invention to provide a kind of ginsenoside Rg1 and be applied to the health product of preparation raising body movement ability.
Experimental result shows, glucose uptake and utilization are had a very important role by the gene expression of GLUT4 and film indexing.Ginsenoside Rg1 can strengthen gene expression and the film indexing of GLUT4, thus promotes that Skeletal Muscle Cell is to glucose uptake and utilization.
First laboratory cultures sarcoplast C2C12 (being purchased from Rui Chu bio tech ltd, Shanghai);Three kinds of variable concentrations (10 on probation, 20,40 μMs) Rg1 (being purchased from prophyll bio tech ltd, Shanghai, Nanjing, purity is 98.0%) hatch altogether with C2C12, GLUT4 is expressed by 20 μMs of concentrations above ginsenoside Rg1s significant facilitation.The experimental techniques such as application RT-PCR, Westernblot, it was demonstrated that after ginsenoside Rg1 and C2C12 cell are hatched altogether, detecting that in C2C12 cell, GLUT4 genetic transcription increases, GLUT4 protein level raises, and GLUT4 is strengthened to after birth indexing by endochylema.
Beneficial effect: the essence improving body movement ability is to strengthen skeletal muscle acting, increasing the supply of Skeletal Muscle Cell energy matter is to strengthen skeletal muscle acting important channel.Ginsenoside Rg1 can promote the expression of Skeletal Muscle Cell GLUT4 and film indexing, improves skeletal muscle to the picked-up of glucose sugar and utilization, and direct support bones flesh does work, and improves body movement ability.
Accompanying drawing explanation
Fig. 1 is that after ginsenoside Rg1 is hatched altogether with C2C12 cell, RT-PCR detects GLUT4mRNA transcriptional level.
Fig. 2 is that after ginsenoside Rg1 is hatched altogether with C2C12 cell, Western blot detects GLUT4 protein expression level.
Fig. 3 is that after ginsenoside Rg1 is hatched altogether with C2C12 cell, Western blot detects cell membrane GLUT4 protein level.
Fig. 4 is after ginsenoside Rg1 is hatched altogether with C2C12 cell, and glucose oxidizing process detection glucose uptake utilizes level.
Detailed description of the invention
1.C2C12 cell is cultivated
Taking out frozen C2C12 cell from-80 DEG C of refrigerators, be quickly transferred in 37 DEG C of water-baths make cell instant, 800r is centrifuged 5 minutes, abandons supernatant.With 10% hyclone DMEM culture fluid at 37 DEG C, 5%CO2In cell culture incubator.Change low concentration serum free culture system liquid and cultivate its differentiation of rush.Change DMEM height sugar culture fluid to cultivate, culture fluid adds ginsenoside Rg1 and hatches altogether.
2.RT-PCR detects GLUT4mRNA
C2C12 cell after incubation 24h, is used Trizol to extract total serum IgE in C2C12 cell, is detected by OD value at 260nm and 280nm in containing ginsenoside Rg1's culture fluid, measures extracted RNA amount and purity.The RT-PCR kit explanation provided according to Takara company carries out reverse transcription and amplification experiment, and primer sequence is as follows: GLUT4 forward primer is 5 '-AGGCTGCCTATAAACACTGG-3 ';GLUT4 downstream primer is 5 '-AGGAAGGATGAAGTGCAAAG-3 '.Selecting annealing temperature is 60 DEG C.1.5% agarose gel electrophoresis is used to analyze PCR primer amount.
3.Western blot detection GLUT4 expresses
C2C12 cell after incubation 24h, extracts total protein and carries out SDS-PAGE in containing ginsenoside Rg1's culture fluid.With Semi-Dry electroporation by the Protein transfer in gel to pvdf membrane.Pvdf membrane after electricity turns is dehydrated in methanol, and defatted milk powder is closed, and an antibody (mountain sheep anti mouse) is hatched jointly with pvdf membrane, and TBST washs, and two antibody (rabbit anti goat igg) are hatched, and TBST washs, with ECL Kit testing goal albumen.
4.Western blot detection GLUT4 film indexing
C2C12 cell is in containing ginsenoside Rg1's culture fluid after incubation 24h, and cell separates through cold phosphate buffer eluting, homogenate, differential centrifugation, plasma membrane, extracts memebrane protein and carries out SDS-PAGE.Method is with 3.
5. glucose consumption detection
C2C12 cell in containing ginsenoside Rg1's culture fluid after incubation 24h, the glucose content in detection culture fluid, with the sugared content average in the multiple hole of non-inoculating cell blank for comparison, calculate other each multiple porocyte consumption to glucose.
6. interpretation of result
(1) ginsenoside Rg1 promotes that C2C12GLUT4mRNA transcribes
The impact that C2C12 cell GLUT4mRNA is transcribed by RT-PCR experiment detection ginsenoside Rg1.RT-PCR result shows, C2C12 cell GLUT4mRNA has been transcribed the effect of being obviously promoted by ginsenoside Rg1, and has concentration dependent, such as Fig. 1.In figure, 1 is matched group, is not added with ginsenoside Rg1;2-4 is that ginsenoside Rg1 hatches group;Ginsenoside Rg1's concentration is respectively 10,20 and 40uM.Wherein, 20 and 40uM groups remarkably promote effect to GLUT4 cell mRNA transcriptional level.
(2) ginsenoside Rg1 promotes C2C12 cell GLUT4 protein expression
Western blot experiment detection ginsenoside Rg1's impact on C2C12 cell GLUT4 protein expression.Western blot result shows, ginsenoside Rg1 is obviously promoted effect to C2C12 cell GLUT4 protein expression, and has concentration dependent, such as Fig. 2.In figure, 1 is matched group, is not added with ginsenoside Rg1;2-4 is that ginsenoside Rg1 hatches group;Ginsenoside Rg1's concentration is respectively 10,20 and 40uM.Wherein, 20 and 40uM groups remarkably promote effect to GLUT4 protein expression.
(3) ginsenoside Rg1 promotes the indexing of C2C12 cell GLUT4 film
The Western blot experiment detection ginsenoside Rg1 impact on the indexing of C2C12 cell GLUT4 albuminous coat.Western blot result shows, ginsenoside Rg1 is obviously promoted effect, such as Fig. 3 to C2C12 cell GLUT4 albuminous coat indexing.In figure, ginsenoside Rg1 hatches group (20 and 40uM) C2C12 cell membrane GLUT4 protein level has notable rising than matched group.
(4) ginsenoside Rg1 promotes C2C12 grape cell Sugar intake
Glucose oxidizing process experiment detection ginsenoside Rg1 utilizes impact on C2C12 cell to glucose uptake.Glucose oxidation experiment result shows, ginsenoside Rg1 can promote C2C12 grape cell Sugar intake, such as Fig. 4.During in figure, ginsenoside Rg1 hatches group (40uM) cell culture fluid, glucose level significantly reduces.
In summary it can be seen, ginsenoside Rg1 can promote osteoblast C2C12GLUT4 genetic transcription and protein expression, and can promote the indexing of GLUT4 film, strengthens C2C12 to the picked-up of glucose and utilization, there is enhancing skeletal muscle acting, improve the effect of body movement ability.

Claims (1)

1. ginsenoside Rg1's application in preparation improves body movement ability health product.It is characterized by: ginsenoside Rg1 can promote Enter the genetic transcription of GLUT4, improve protein expression level and film indexing, thus strengthen Skeletal Muscle Cell to the picked-up of glucose and Utilize.
CN201510233880.1A 2015-05-11 2015-05-11 Ginsenoside Rg1's application in preparation improves body movement ability health product Pending CN106265703A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201510233880.1A CN106265703A (en) 2015-05-11 2015-05-11 Ginsenoside Rg1's application in preparation improves body movement ability health product

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201510233880.1A CN106265703A (en) 2015-05-11 2015-05-11 Ginsenoside Rg1's application in preparation improves body movement ability health product

Publications (1)

Publication Number Publication Date
CN106265703A true CN106265703A (en) 2017-01-04

Family

ID=57630789

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201510233880.1A Pending CN106265703A (en) 2015-05-11 2015-05-11 Ginsenoside Rg1's application in preparation improves body movement ability health product

Country Status (1)

Country Link
CN (1) CN106265703A (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN107836708A (en) * 2017-10-31 2018-03-27 北京同仁堂健康药业股份有限公司 A kind of composition for promoting muscle synthesis and preparation method thereof
CN108061795A (en) * 2017-11-24 2018-05-22 大连医科大学 Improve the protein immunoblotting method of detection sensitivity

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101254199A (en) * 2008-02-26 2008-09-03 喜巍 Panax saponin Rg1 and thein combination and uses thereof

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101254199A (en) * 2008-02-26 2008-09-03 喜巍 Panax saponin Rg1 and thein combination and uses thereof

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
HYE-MIN LEE ET AL.: ""Ginsenoside Rg1 Promotes Glucose Uptake Through Activated AMPK Pathway in Insulin-resistant Muscle Cells"", 《PHYTOTHERAPY RESEARCH》 *
唐晖等: ""人参皂甙Rg1调节大鼠运动中及运动后糖代谢的机制研究"", 《沈阳体育学院学报》 *

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN107836708A (en) * 2017-10-31 2018-03-27 北京同仁堂健康药业股份有限公司 A kind of composition for promoting muscle synthesis and preparation method thereof
CN108061795A (en) * 2017-11-24 2018-05-22 大连医科大学 Improve the protein immunoblotting method of detection sensitivity

Similar Documents

Publication Publication Date Title
CN102078021B (en) Functional health care drink
CN103505717B (en) A kind of compositions and application thereof containing shiitake mushroom hypha polysaccharide
TWI671081B (en) The use of composition containing a plant extracts for enhancing the gene expression of transglutaminase 1, keratin, aquaporin 3, filaggrin, , glucocerebrosidase, hyaluronan synthase
CN104256584A (en) Moringa oleifera ferment and preparation method thereof
CN104257696B (en) A kind of steady sugar yeast bacterium powder of hypoglycemic and its preparation method and application
CN103820517A (en) Preparation method for yak skin micromolecular collagen capable of regulating human body energy metabolism
CN102754696B (en) Winterworm summerherb strain and winterworm summerherb walnut peptide health drink prepared from same
CN106265703A (en) Ginsenoside Rg1's application in preparation improves body movement ability health product
CN111588755A (en) Plant fermentation product, preparation method thereof and application of plant fermentation product in liver health care
Lee et al. Hematopoietic effect of Bacillus subtilis–fermented antler extract on phenylhydrazine-induced hemolytic anemia in Sprague–Dawley rats
WO2016141775A1 (en) Uses of jilin ginseng oligopeptide in preparing food product or healthcare food product for combating fatigue
KR20170116532A (en) Maca and date palms, Ganoderma lucidum, perform exercises containing fermented antler extract as an active ingredient skills enhancement and promotion fatigue complex composition
WO2014026333A1 (en) Extraction, preparation, and application of plant micro-ribonucleic acid
CN103710315B (en) From the long-chain-acyl-CoA synthetase of Cordyceps sinensis, gene and application
CN116440035A (en) Regulator of biological rhythm gene expression quantity, application thereof, skin care product and cosmetics
CN107200684B (en) Method for extracting myristic acid from marine coccolithosiphon
CN101721613B (en) Composition for enhancing constitution and preparation method thereof
CN101401646A (en) Soup additive
Abdelazim et al. Oyster mushroom (Pleurotus ostreatus) strain 238 ameliorates the oxidative stress in STZ-induced diabetic mice
CN110123824B (en) Ilicis Pubescentis saponin A1New use of
CN111773323A (en) Application of dendrobium water extract in treating type 2 diabetes
Zhang et al. Anti-fatigue activities of anthocyanins from Lycium ruthenicum Murry
CN112190644A (en) Plant fermentation product, preparation method thereof and application of plant fermentation product in stomach health care
CN1350861A (en) Process for preparing health-care oral liquid to prevent cancer and delay sanility
CN109328874A (en) A kind of biologic ferment composition and its method for promoting cordyceps sinensis fermentation level

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
WD01 Invention patent application deemed withdrawn after publication

Application publication date: 20170104

WD01 Invention patent application deemed withdrawn after publication